ArticleLeukemia2025

Genome-wide CRISPR screen identifies MAD2L1BP and ANAPC15 as targets for brentuximab vedotin sensitivity in CD30+ peripheral T-cell lymphoma.

Keito Suto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.